Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
3 Stocks That Might Soar With Pills for COVID
October 03, 2021
Tickers
AVIR
MRK
MRNA
NVAX
Tags
REGN
MRNA
PFE
From
Motley Fool
Here Are the Leaders in the Race to Develop a COVID-19 Pill
October 03, 2021
Tickers
AVIR
MRK
PFE
RDHL
Tags
REGN
RDHL
RHHBY
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
October 01, 2021
Tickers
ANIP
AVDL
BHC
CALT
Tags
OYST
SGEN
SNY
From
Benzinga
Labcorp's At Home Collection Kit Gets EUA Nod For Combined COVID-19 and Flu Detection
October 01, 2021
Tickers
LH
RHHBF
RHHBY
RHHVF
Tags
RHHVF
Health Care
News
From
Benzinga
BioNTech Starts Dosing In Mid-Stage Colorectal Cancer Immunotherapy Trial
October 01, 2021
Tickers
BNTX
RHHBF
RHHBY
RHHVF
Tags
colorectal cancer
General
Benzinga
From
Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Tickers
ABBV
ADMA
AGTC
AIM
Tags
KTRA
M&A
AIM
From
Benzinga
Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail
September 30, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Benzinga
General
Biotech
From
Benzinga
3 COVID Stocks Ready to Take On the Delta Variant
September 27, 2021
Tickers
BNTX
GILD
LLY
NVAX
Tags
BNTX
Market News
RHHBY
From
Motley Fool
Glaxo - Vir Biotech's COVID Treatment Approved In Japan
September 27, 2021
Tickers
GSK
REGN
RHHBF
RHHBY
Tags
News
REGN
RHHVF
From
Benzinga
3 Biotech Stocks That Could Make You Filthy Rich
September 27, 2021
Tickers
ADAP
AMGN
AZN
CHGCY
Tags
CRVS
ADAP
MRNA
From
Motley Fool
Acceleron In Advanced $11B Buyout Talks: Bloomberg
September 27, 2021
Tickers
AMGN
BMY
GILD
MRK
Tags
RHHBF
XLRN
Market News
From
Benzinga
September Sell-Off Alert: Buy Vertex Pharmaceuticals on the Dip
September 25, 2021
Tickers
CRSP
NDAQ
RHHBY
VRTX
Tags
VRTX
RHHBY
CRSP
From
Motley Fool
Roche Builds Case For Evrysdi Benefits In Younger Spinal Muscular Atrophy Patients
September 24, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
News
General
Benzinga
From
Benzinga
WHO Backs Regeneron COVID-19 Antibody Cocktail As It Calls For Equal Access
September 24, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Biotech
RHHBY
Government
From
Benzinga
Here's Why Everyone's Talking About AstraZeneca Right Now
September 21, 2021
Tickers
AZN
DSNKY
RHHBY
Tags
RHHBY
AZN
Market News
From
Motley Fool
AstraZeneca's Enhertu Posts Substantial Clinical Benefit Over Roche's Kadcyla In Breast Cancer Trials
September 20, 2021
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
News
Trading Ideas
breast cancer
From
Benzinga
With Prothena Up Over 500% This Year, Is It Too Late to Get in?
September 18, 2021
Tickers
BIIB
BMY
NVO
PRTA
Tags
BIIB
Market News
NVO
From
Motley Fool
Why Adaptimmune Therapeutics Was Sinking This Week
September 17, 2021
Tickers
ADAP
RHHBY
Tags
Market News
RHHBY
ADAP
From
Motley Fool
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
Tickers
ABCL
ABSI
AGEN
ALZN
Tags
OYST
VERA
CYTK
From
Benzinga
Biogen Launches High-Dose Spinraza Trial In Evrysdi Treated Patients: What You Need To Know
September 15, 2021
Tickers
BIIB
RHHBF
RHHBY
RHHVF
Tags
BIIB
Benzinga
General
From
Benzinga
Novocure To Test Its Tumor Treating Fields With Roche's Tecentriq In Pancreatic Cancer
September 14, 2021
Tickers
NVCR
RHHBF
RHHBY
RHHVF
Tags
News
RHHVF
Health Care
From
Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Tickers
ABT
ACAD
ADGI
ALPMY
Tags
MOR
HGEN
ESPR
From
Benzinga
These OTCQX & OTCQB Securities Had the Most Trading Activity in August
September 13, 2021
Tickers
BLLYF
ETHE
GBTC
GDLC
Tags
Partner Content
Benzinga
MLYF
From
Benzinga
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
September 12, 2021
Tickers
ALRN
AZN
BIIB
BNTX
Tags
ALRN
MRK
AZN
From
Benzinga
7 Biotech Stocks to Buy That Have Millionaire-Maker Potential
September 10, 2021
Tickers
AVIR
HSTO
MRNA
NRBO
Tags
AVIR
PFE
SYN
From
InvestorPlace
Why MacroGenics Soared Nearly 9% Higher Today
September 09, 2021
Tickers
MGNX
RHHBY
Tags
RHHBY
MGNX
Market News
From
Motley Fool
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Tickers
ABSI
ABT
AZN
BIVI
Tags
IBB
ABT
SBTX
From
Benzinga
Roche Beefs Up PCR-Test Portfolio With TIB Molbiol Acquisition
September 09, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHBY
Market News
From
Benzinga
2 Stocks I Bought Last Week
September 08, 2021
Tickers
AZN
JYNT
NVAX
PIRS
Tags
JYNT
NVAX
UPS
From
Motley Fool
MacroGenics' Cancer Drug Margenza Flops On Overall Survival Analysis
September 08, 2021
Tickers
MGNX
RHHBF
RHHBY
RHHVF
Tags
Phase 3 Trial
RHHBY
Biotech
From
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.